Reynolds AB (June 2011). "Epithelial organization: new perspective on α-catenin from an ancient source". Curr. Biol.21 (11): R430–2. PMID21640901. doi:10.1016/j.cub.2011.04.043.
Fukunaga Y, Liu H, Shimizu M, Komiya S, Kawasuji M, Nagafuchi A (2005). "Defining the roles of β-catenin and plakoglobin in cell-cell adhesion: isolation of β-catenin/plakoglobin-deficient F9 cells". Cell Struct. Funct.30 (2): 25–34. PMID16357441. doi:10.1247/csf.30.25.
Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E (February 2001). "Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin". Cell104 (4): 605–17. PMID11239416. doi:10.1016/S0092-8674(01)00246-X.
Tripathi V, Popescu NC, Zimonjic DB (April 2012). "DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity". Mol Cell Biol32 (11): 2145–59. PMID22473989. doi:10.1128/MCB.06580-11.
Buda A, Pignatelli M (December 2011). "E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis". Cell Commun. Adhes.18 (6): 133–43. PMID22176698. doi:10.3109/15419061.2011.636465.
Tanaka T, Iino M, Goto K (March 2012). "Knockdown of Sec6 improves cell-cell adhesion by increasing α-E-catenin in oral cancer cells". FEBS Lett.586 (6): 924–33. PMID22381337. doi:10.1016/j.febslet.2012.02.026.
Flores ER, Halder G (2011). "Stem cell proliferation in the skin: alpha-catenin takes over the hippo pathway". Sci Signal4 (183): pe34. PMID21791701. doi:10.1126/scisignal.2002311.
Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V (2011). "α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1". Sci Signal4 (174): ra33. PMID21610251. doi:10.1126/scisignal.2001823.
Drivalos A, Papatsoris AG, Chrisofos M, Efstathiou E, Dimopoulos MA (2011). "The role of the cell adhesion molecules (integrins/cadherins) in prostate cancer". Int Braz J Urol37 (3): 302–6. PMID21756376. doi:10.1590/S1677-55382011000300002.
Zhang F, Meng F, Li H, Dong Y, Yang W, Han A (September 2011). "Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma". Eur. J. Cancer47 (13): 2060–7. PMID21561764. doi:10.1016/j.ejca.2011.04.010.
Guardavaccaro D, Clevers H (2012). "Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields". Sci Signal5 (219): pe15. PMID22494969. doi:10.1126/scisignal.2002921.
Zhao JH, Luo Y, Jiang YG, He DL, Wu CT (July 2011). "Knockdown of β-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1α". Cancer Invest.29 (6): 377–82. PMID21649463. doi:10.3109/07357907.2010.512595.
Yi ZY, Feng LJ, Xiang Z, Yao H (2011). "Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells". J Invest Surg24 (2): 67–76. PMID21345006. doi:10.3109/08941939.2010.542272.
Spivey KA, Chung I, Banyard J, Adini I, Feldman HA, Zetter BR (October 2011). "A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis". Oncogene31 (18): 2362–72. PMID21963851. doi:10.1038/onc.2011.406.
Yamashita K, Ougolkov AV, Nakazato H, Ito K, Ohashi Y, Kitakata H, Yasumoto K, Omote K, Mai M, Takahashi Y, Minamoto T (August 2007). "Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation". Dis. Colon Rectum50 (8): 1169–81. PMID17347903. doi:10.1007/s10350-006-0842-5.
Gassler N, Herr I, Keith M, Autschbach F, Schmitz-Winnenthal H, Ulrich A, Otto HF, Kartenbeck J, Z'graggen K (December 2004). "Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer". Int. J. Oncol.25 (6): 1543–9. PMID15547689. doi:10.3892/ijo.25.6.1543.
Munding J, Ziebarth W, Pox CP, Ladigan S, Reiser M, Hüppe D, Brand L, Schmiegel W, Tannapfel A, Reinacher-Schick AC (March 2012). "The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway". Carcinogenesis33 (3): 637–43. PMID22198215. doi:10.1093/carcin/bgr306.
Song S, Christova T, Perusini S, Alizadeh S, Bao RY, Miller BW, Hurren R, Jitkova Y, Gronda M, Isaac M, Joseph B, Subramaniam R, Aman A, Chau A, Hogge DE, Weir SJ, Kasper J, Schimmer AD, Al-awar R, Wrana JL, Attisano L (December 2011). "Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers". Cancer Res.71 (24): 7628–39. PMID22009536. doi:10.1158/0008-5472.CAN-11-2745.
Nam JS, Ino Y, Sakamoto M, Hirohashi S (September 2002). "Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis". Jpn. J. Cancer Res.93 (9): 1020–8. PMID12359056. doi:10.1111/j.1349-7006.2002.tb02479.x.
Singh M, Darcy KM, Brady WE, Clubwala R, Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC, Leslie KK (November 2011). "Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial". Gynecol. Oncol.123 (2): 320–8. PMID21813170. doi:10.1016/j.ygyno.2011.07.005.
Coluzzi F, Mandatori I, Mattia C (September 2011). "Emerging therapies in metastatic bone pain". Expert Opin Emerg Drugs16 (3): 441–58. PMID21545247. doi:10.1517/14728214.2011.576668.
nih.gov
ncbi.nlm.nih.gov
Weis WI, Nelson WJ (November 2006). "Re-solving the cadherin-catenin-actin conundrum". J. Biol. Chem.281 (47): 35593–7. PMID17005550. doi:10.1074/jbc.R600027200.
Reynolds AB (June 2011). "Epithelial organization: new perspective on α-catenin from an ancient source". Curr. Biol.21 (11): R430–2. PMID21640901. doi:10.1016/j.cub.2011.04.043.
Fukunaga Y, Liu H, Shimizu M, Komiya S, Kawasuji M, Nagafuchi A (2005). "Defining the roles of β-catenin and plakoglobin in cell-cell adhesion: isolation of β-catenin/plakoglobin-deficient F9 cells". Cell Struct. Funct.30 (2): 25–34. PMID16357441. doi:10.1247/csf.30.25.
Bierkamp C, Schwarz H, Huber O, Kemler R (January 1999). "Desmosomal localization of β-catenin in the skin of plakoglobin null-mutant mice". Development126 (2): 371–81. PMID9847250.
Vasioukhin V, Bauer C, Degenstein L, Wise B, Fuchs E (February 2001). "Hyperproliferation and defects in epithelial polarity upon conditional ablation of alpha-catenin in skin". Cell104 (4): 605–17. PMID11239416. doi:10.1016/S0092-8674(01)00246-X.
Tripathi V, Popescu NC, Zimonjic DB (April 2012). "DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity". Mol Cell Biol32 (11): 2145–59. PMID22473989. doi:10.1128/MCB.06580-11.
Buda A, Pignatelli M (December 2011). "E-cadherin and the cytoskeletal network in colorectal cancer development and metastasis". Cell Commun. Adhes.18 (6): 133–43. PMID22176698. doi:10.3109/15419061.2011.636465.
Tanaka T, Iino M, Goto K (March 2012). "Knockdown of Sec6 improves cell-cell adhesion by increasing α-E-catenin in oral cancer cells". FEBS Lett.586 (6): 924–33. PMID22381337. doi:10.1016/j.febslet.2012.02.026.
Flores ER, Halder G (2011). "Stem cell proliferation in the skin: alpha-catenin takes over the hippo pathway". Sci Signal4 (183): pe34. PMID21791701. doi:10.1126/scisignal.2002311.
Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD, Lantz DM, Seykora JT, Vasioukhin V (2011). "α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1". Sci Signal4 (174): ra33. PMID21610251. doi:10.1126/scisignal.2001823.
Drivalos A, Papatsoris AG, Chrisofos M, Efstathiou E, Dimopoulos MA (2011). "The role of the cell adhesion molecules (integrins/cadherins) in prostate cancer". Int Braz J Urol37 (3): 302–6. PMID21756376. doi:10.1590/S1677-55382011000300002.
Zhang F, Meng F, Li H, Dong Y, Yang W, Han A (September 2011). "Suppression of retinoid X receptor alpha and aberrant β-catenin expression significantly associates with progression of colorectal carcinoma". Eur. J. Cancer47 (13): 2060–7. PMID21561764. doi:10.1016/j.ejca.2011.04.010.
Guardavaccaro D, Clevers H (2012). "Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields". Sci Signal5 (219): pe15. PMID22494969. doi:10.1126/scisignal.2002921.
Zhao JH, Luo Y, Jiang YG, He DL, Wu CT (July 2011). "Knockdown of β-Catenin through shRNA cause a reversal of EMT and metastatic phenotypes induced by HIF-1α". Cancer Invest.29 (6): 377–82. PMID21649463. doi:10.3109/07357907.2010.512595.
Yi ZY, Feng LJ, Xiang Z, Yao H (2011). "Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells". J Invest Surg24 (2): 67–76. PMID21345006. doi:10.3109/08941939.2010.542272.
Spivey KA, Chung I, Banyard J, Adini I, Feldman HA, Zetter BR (October 2011). "A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis". Oncogene31 (18): 2362–72. PMID21963851. doi:10.1038/onc.2011.406.
Yamashita K, Ougolkov AV, Nakazato H, Ito K, Ohashi Y, Kitakata H, Yasumoto K, Omote K, Mai M, Takahashi Y, Minamoto T (August 2007). "Adjuvant immunochemotherapy with protein-bound polysaccharide K for colon cancer in relation to oncogenic β-catenin activation". Dis. Colon Rectum50 (8): 1169–81. PMID17347903. doi:10.1007/s10350-006-0842-5.
Gassler N, Herr I, Keith M, Autschbach F, Schmitz-Winnenthal H, Ulrich A, Otto HF, Kartenbeck J, Z'graggen K (December 2004). "Wnt-signaling and apoptosis after neoadjuvant short-term radiotherapy for rectal cancer". Int. J. Oncol.25 (6): 1543–9. PMID15547689. doi:10.3892/ijo.25.6.1543.
Munding J, Ziebarth W, Pox CP, Ladigan S, Reiser M, Hüppe D, Brand L, Schmiegel W, Tannapfel A, Reinacher-Schick AC (March 2012). "The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway". Carcinogenesis33 (3): 637–43. PMID22198215. doi:10.1093/carcin/bgr306.
Song S, Christova T, Perusini S, Alizadeh S, Bao RY, Miller BW, Hurren R, Jitkova Y, Gronda M, Isaac M, Joseph B, Subramaniam R, Aman A, Chau A, Hogge DE, Weir SJ, Kasper J, Schimmer AD, Al-awar R, Wrana JL, Attisano L (December 2011). "Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers". Cancer Res.71 (24): 7628–39. PMID22009536. doi:10.1158/0008-5472.CAN-11-2745.
Nam JS, Ino Y, Sakamoto M, Hirohashi S (September 2002). "Ras farnesylation inhibitor FTI-277 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis". Jpn. J. Cancer Res.93 (9): 1020–8. PMID12359056. doi:10.1111/j.1349-7006.2002.tb02479.x.
Singh M, Darcy KM, Brady WE, Clubwala R, Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC, Leslie KK (November 2011). "Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial". Gynecol. Oncol.123 (2): 320–8. PMID21813170. doi:10.1016/j.ygyno.2011.07.005.
Coluzzi F, Mandatori I, Mattia C (September 2011). "Emerging therapies in metastatic bone pain". Expert Opin Emerg Drugs16 (3): 441–58. PMID21545247. doi:10.1517/14728214.2011.576668.
Yang C, Iyer RR, Yu AC, Yong RL, Park DM, Weil RJ, Ikejiri B, Brady RO, Lonser RR, Zhuang Z. β-Catenin signaling initiates the activation of astrocytes and its dysregulation contributes to the pathogenesis of astrocytomas. Proc Natl Acad Sci U S A. 2012 May 1;109(18):6963-8. doi: 10.1073/pnas.1118754109. Epub 2012 Apr 13. PubMed PMID 22505738; PubMed Central PMCID: PMC3344971.
sinobiological.com
"β-Catenin". Sino Biological Inc.: Biological Solution Specialist.
